Functional characterization of 22 novel CYP2D6 variants for the metabolism of Tamoxifen

被引:3
作者
Hu, Xiao-Xia [1 ]
Zhou, Quan [1 ]
Lan, Tian [1 ]
Huang, Xiang-Xin [1 ]
Liang, Bing-qing [1 ]
Dai, Da-Peng [2 ,3 ]
Cai, Jian-Ping [2 ,3 ]
Hu, Guo-Xin [1 ]
机构
[1] Wenzhou Med Univ, Sch Pharm, Dept Pharmacol, Wenzhou, Zhejiang, Peoples R China
[2] Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China
[3] Minist Hlth, Beijing Inst Geriatr, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
allelic variants; CYP2D6; polymorphism; drug metabolism; tamoxifen; CYTOCHROME-P450; 2D6; GENETIC POLYMORPHISMS; CHINESE POPULATION; BREAST-CANCER; IN-VITRO; DEXTROMETHORPHAN; CONSEQUENCES; FREQUENCIES; ALLELE; WOMEN;
D O I
10.1111/jphp.12556
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives This study aimed to assess the catalytic characteristics of 24 CYP2D6 allelic isoforms found in Chinese Han population on the metabolism of tamoxifen in vitro. Methods Recombinant CYP2D6 microsomes of distinguished genotypes were used to characterize the corresponding enzyme activity towards tamoxifen. About 5-2500 mu M tamoxifen was incubated for 30 min at 37 degrees C. Using high-performance liquid chromatography to detect the products, the kinetic parameters Km, V-max and intrinsic clearance (V-max/K-m) of N-desmethyltamoxifen were determined. Key findings Of the 24 tested allelic variants, the differences of intrinsic clearance value were shown as follows: CYP2D6.89 was much higher than wild-type CYP2D6.1, 2 allelic isoforms (CYP2D6.88 and D336N) exhibited similar intrinsic clearance values as the wild-type enzyme, two variants displayed weak or no activity, while the rest 19 variants showed significantly reduced intrinsic clearance values ranging from 7.46 to 81.11%. Conclusion The comprehensive assessment of CYP2D6 variants provides significant insights into allele-specific activity towards tamoxifen in vitro, suggesting that most of the carriers of these alleles might be paid more attention when using CYP2D6-mediated drugs clinically.
引用
收藏
页码:819 / 825
页数:7
相关论文
共 25 条
  • [11] SALIVARY ANALYSIS FOR DETERMINATION OF DEXTROMETHORPHAN METABOLIC PHENOTYPE
    HOU, ZY
    PICKLE, LW
    MEYER, PS
    WOOSLEY, RL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (04) : 410 - 419
  • [12] Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
    Ingelman-Sundberg, M
    [J]. PHARMACOGENOMICS JOURNAL, 2005, 5 (01) : 6 - 13
  • [13] Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population
    Jin, Tian-Bo
    Ma, Li-Feng
    Zhang, Jia-Yi
    Yuan, Dong-Ya
    Sun, Qiang
    Zong, Ting-Yong
    Geng, Ting-Ting
    Cui, Ya-Li
    Kang, Long-Li
    Chen, Chao
    [J]. GENE, 2013, 527 (01) : 360 - 365
  • [14] Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma
    Muerdter, T. E.
    Schroth, W.
    Bacchus-Gerybadze, L.
    Winter, S.
    Heinkele, G.
    Simon, W.
    Fasching, P. A.
    Fehm, T.
    Eichelbaum, M.
    Schwab, M.
    Brauch, H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (05) : 708 - 717
  • [15] Genetic variations of human CYP2D6 in the Chinese Han population
    Qian, Jian-Chang
    Xu, Xin-Min
    Hu, Guo-Xin
    Dai, Da-Peng
    Xu, Ren-Ai
    Hu, Li-Ming
    Li, Fang-Hong
    Zhang, Xiu-Hua
    Yang, Jie-Fu
    Cai, Jian-Ping
    [J]. PHARMACOGENOMICS, 2013, 14 (14) : 1731 - 1743
  • [16] Sachse C, 1997, AM J HUM GENET, V60, P284
  • [17] Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen
    Schultink, Aurelia H. M. de Vries
    Zwart, Wilbert
    Linn, Sabine C.
    Beijnen, Jos H.
    Huitema, Alwin D. R.
    [J]. CLINICAL PHARMACOKINETICS, 2015, 54 (08) : 797 - 810
  • [18] Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17
    Shen, Hongwu
    He, Minxia M.
    Liu, Houfu
    Wrighton, Steven A.
    Wang, Li
    Guo, Bin
    Li, Chuan
    [J]. DRUG METABOLISM AND DISPOSITION, 2007, 35 (08) : 1292 - 1300
  • [19] Investigational study of tamoxifen phase I metabolites using chromatographic and spectroscopic analytical techniques
    Teunissen, S. F.
    Rosing, H.
    Seoane, M. Dominguez
    Brunsveld, L.
    Schellens, J. H. M.
    Schinkel, A. H.
    Beijnen, J. H.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 55 (03) : 518 - 526
  • [20] Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population
    Wang, Hui-Hung
    Liao, Yie-Wen
    Chiang, Hung-Lun
    Wu, Jer-Yuarn
    Chen, Yuan-Tsong
    [J]. PHARMACOGENOMICS, 2009, 10 (03) : 359 - 374